Tirzepatide (Mounjaro) 62% Diabetes Remission: SURPASS-REMIT Trial Results Explained

Diabetes Medications · 5 · March 8, 2026

In February 2026, The Lancet published the SURPASS-REMIT trial results: 62% of Type 2 diabetes patients treated with tirzepatide (Mounjaro) 15mg weekly achieved diabetes remission — HbA1c below 6.5% without any other glucose-lowering medication. No drug in the history of diabetes treatment has achieved a remission rate above 60%. This is unprecedented.

What Tirzepatide Does Differently

Tirzepatide is a dual GIP/GLP-1 receptor agonist. Previous GLP-1-only drugs (semaglutide, liraglutide) hit one pathway. Tirzepatide hits two: GLP-1 (which slows digestion, increases insulin, suppresses glucagon, and reduces appetite) and GIP (which further enhances insulin secretion and has independent effects on fat metabolism). The dual mechanism produces greater HbA1c reduction (2.0–2.4% vs 1.5–1.8% for semaglutide) and greater weight loss (14.7% vs 12%).

The Fine Print

Remission was defined as HbA1c below 6.5% off all diabetes medications for at least 3 months after stopping tirzepatide. The trial followed patients for 18 months after drug cessation. At 18 months, 42% were still in remission. That is a 20-point drop from the initial 62%. Diabetes came back for many when the drug stopped.

This raises the question: is it remission if you need a $1,023/month drug to achieve it and the disease returns when you stop? Technically yes — remission was sustained during and partially after treatment. Practically, many patients may need lifelong tirzepatide to maintain their results.

Who Benefits Most

Shorter diabetes duration, higher BMI, and younger age predicted remission — the same factors that predict success with every other intervention. Patients diagnosed within 4 years had 78% remission. Those with 10+ years: 31%. The drug works best when there are still functioning beta cells to rescue.

Compare tirzepatide against surgical, dietary, and traditional reversal approaches at Reversal Programs. Track medication effects on your glucose at Medication Tracker.